论文部分内容阅读
We have previously shown that tumor cellsgenetically modified to co-express IL-4 or IL-7 and B7. 1have increased immunogenicity and provided vaccinessuperior to single gene transfectants or tumor cells/adjuvant mixture. Tumor antigens can be presented eit